Table 3.
Team requesting/performing studies | Clinical studies | Timing |
---|---|---|
Organ donor network | Serum: HIV 1,2 antibody; HTLV 1,2 antibody; Hepatitis B surface antigen, Hepatitis B core antibody, Hepatitis B core IgM, Hepatitis C antibody, Hepatitis B/C and HIV RNA testing, CMV IgM and IgG, EBV IgM and IgG, RPR, toxoplasmosis IgG, Chagas disease antibody (for patients with travel to Texas or South America) | Once |
Primary care team | Serum: Complete blood count, arterial blood gas, liver function tests including GGT, coagulation studies, fibrinogen, troponin/CK, chemistry panel including calcium, phospohorus and magnesium, LDH, amylase, lipase | Every 6 h |
Primary care team | CXR, ECG, blood culture, urine culture, urinalysis, sputum culture and gram stain, HgbA1c (once), type and screen (once) | Daily and as needed |
Primary care team | 2-D Transthoracic echocardiogram | At least once, may repeat depending on hemodynamic status |
Organ donor network/primary care team/cardiology | Coronary catheterization | May be required for potential heart donors |
Organ donor network/primary care team/pulmonology | Bronchoscopy | Required for potential lung donors |
HTLV Human T lymphotrophic virus, EBV Epstein-Barr virus, CMV cytomegalovirus, CXR chest X-ray, ECG electrocardiogram